News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Actavis Names Claudio Albrecht New Chief Executive
June 23, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
DOW JONES NEWSWIRES -- Icelandic generic drug maker Actavis Group (ACT-IC) Wednesday named Claudio Albrecht as new chief executive, succeeding Sigurdur Oli Olafsson, who is stepping down after working for the company for seven years.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Government
Prasad ally Szarama exits CBER after 3 weeks as FDA cleanout continues
May 18, 2026
·
1 min read
·
Tristan Manalac
Layoff Tracker
Takeda cuts 4,500, Novartis lays off biomedical research staff
May 15, 2026
·
54 min read
·
BioSpace Editorial Staff
Drug Development
Genmab drops 2 antibody assets, including another ProfoundBio ADC
May 15, 2026
·
2 min read
·
Gabrielle Masson
Manufacturing
Sun Pharma recalls cancer drug after finding glass particles in some vials
May 15, 2026
·
2 min read
·
Nick Paul Taylor
